CIK 0001123494
- Non-accelerated filer
- Smaller reporting company
HARVARD BIOSCIENCE INC
Sign in to watch- Ticker
- HBIO
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043306140
- Phone
- +1 508-893-8999
- Business address
- 84 OCTOBER HILL RD, HOLLISTON, MA, 01746
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-26 | Unninayar Kamalam Chief Financial Officer | Grant or award | +18,469 | 18,469 | ||
| 2018-11-26 | Unninayar Kamalam Chief Financial Officer | Grant or award · Stock option (right to buy) | +44,585 | 44,585 | ||
| 2018-08-29 | Green James W Director | Purchase | +2,500 | $5.74 | $14K | 159,812 |
| 2018-08-29 | Green James W Director | Purchase | +2,500 | $5.74 | $14K | 154,187 |
| 2018-08-29 | Gagnon Robert E. Chief Financial Officer | Sale | −8,889 | $5.77 | $51K | 321,169 |
| 2018-08-14 | Sun Yong VP - Commercial Operations | Exercise or conversion | +50,000 | $4.31 | $216K | 299,732 |
| 2018-08-14 | Sun Yong VP - Commercial Operations | Shares withheld for taxes | −37,588 | $6.65 | $250K | 262,144 |
| 2018-08-14 | Sun Yong VP - Commercial Operations | Exercise or conversion · Stock option (right to buy) | −50,000 | 0 | ||
| 2018-08-09 | Duchemin Jeffrey Chief Executive Officer | Exercise or conversion | +44,500 | $4.31 | $192K | 835,242 |
| 2018-08-09 | Duchemin Jeffrey Chief Executive Officer | Sale | −44,500 | $6.41 | $285K | 790,742 |
| 2018-08-09 | Duchemin Jeffrey Chief Executive Officer | Exercise or conversion · Stock option (right to buy) | −44,500 | 350,000 | ||
| 2018-08-08 | Duchemin Jeffrey Chief Executive Officer | Exercise or conversion | +5,500 | $4.31 | $24K | 796,242 |
| 2018-08-08 | Duchemin Jeffrey Chief Executive Officer | Sale | −5,500 | $6.35 | $35K | 790,742 |
| 2018-08-08 | Duchemin Jeffrey Chief Executive Officer | Exercise or conversion · Stock option (right to buy) | −5,500 | 394,500 | ||
| 2018-08-07 | Duchemin Jeffrey Chief Executive Officer | Exercise or conversion | +100,000 | $4.31 | $431K | 890,742 |
| 2018-08-07 | Duchemin Jeffrey Chief Executive Officer | Sale | −100,000 | $6.07 | $607K | 790,742 |
| 2018-08-07 | Duchemin Jeffrey Chief Executive Officer | Exercise or conversion · Stock option (right to buy) | −100,000 | 400,000 | ||
| 2018-08-07 | Gagnon Robert E. Chief Financial Officer | Exercise or conversion | +30,000 | $4.31 | $129K | 391,801 |
| 2018-08-07 | Gagnon Robert E. Chief Financial Officer | Exercise or conversion | +20,000 | $4.12 | $82K | 411,801 |
| 2018-08-07 | Gagnon Robert E. Chief Financial Officer | Exercise or conversion | +37,500 | $5.56 | $209K | 449,301 |
Page 14 of 17 · 324 trades